-
1
-
-
33644543761
-
Expanding insights of mitochondrial dysfunction in Parkinson's disease
-
Abou-Sleiman PM, Muqit MM, and Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci 7: 207-219, 2006.
-
(2006)
Nat Rev Neurosci
, vol.7
, pp. 207-219
-
-
Abou-Sleiman, P.M.1
Muqit, M.M.2
Wood, N.W.3
-
2
-
-
0037083131
-
Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma
-
Abramova NA, Cassarino DS, Khan SM, Painter TW, and Bennett JP Jr. Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma. J Neurosci Res 67: 494-500, 2002.
-
(2002)
J Neurosci Res
, vol.67
, pp. 494-500
-
-
Abramova, N.A.1
Cassarino, D.S.2
Khan, S.M.3
Painter, T.W.4
Bennett Jr., J.P.5
-
3
-
-
0016652087
-
Brain peroxidase and catalase in Parkinson disease
-
Ambani LM, Van Woert MH, and Murphy S. Brain peroxidase and catalase in Parkinson disease. Arch Neurol 32: 114-118, 1975.
-
(1975)
Arch Neurol
, vol.32
, pp. 114-118
-
-
Ambani, L.M.1
Van Woert, M.H.2
Murphy, S.3
-
4
-
-
33644875954
-
Neuronal protection by sirtuins in Alzheimer's disease
-
Anekonda TS and Reddy PH. Neuronal protection by sirtuins in Alzheimer's disease. J Neurochem 96: 305-313, 2006.
-
(2006)
J Neurochem
, vol.96
, pp. 305-313
-
-
Anekonda, T.S.1
Reddy, P.H.2
-
5
-
-
0031916812
-
Complex I defect in muscle from patients with Huntington's disease
-
Arenas J, Campos Y, Ribacoba R, Martin MA, Rubio JC, Ablanedo P, and Cabello A. Complex I defect in muscle from patients with Huntington's disease. Ann Neurol 43: 397-400, 1998.
-
(1998)
Ann Neurol
, vol.43
, pp. 397-400
-
-
Arenas, J.1
Campos, Y.2
Ribacoba, R.3
Martin, M.A.4
Rubio, J.C.5
Ablanedo, P.6
Cabello, A.7
-
6
-
-
0026711197
-
Abnormal brain and muscle energy metabolism shown by 3IP magnetic resonance spectroscopy in patients affected by migraine with aura
-
Barbirolli B, Montagna P, Cortelli P, Fanicello R, Iotti S, and Munari L. Abnormal brain and muscle energy metabolism shown by 3IP magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 42: 1209-1214, 1992.
-
(1992)
Neurology
, vol.42
, pp. 1209-1214
-
-
Barbirolli, B.1
Montagna, P.2
Cortelli, P.3
Fanicello, R.4
Iotti, S.5
Munari, L.6
-
7
-
-
8444250688
-
Mitochondria-derived oxidative stress induces a heat shock protein response
-
Barrett MJ, Alones V, Wang KX, Phan L, and Swerdlow RH. Mitochondria-derived oxidative stress induces a heat shock protein response. J NEurosci Res 78: 420-429, 2004.
-
(2004)
J NEurosci Res
, vol.78
, pp. 420-429
-
-
Barrett, M.J.1
Alones, V.2
Wang, K.X.3
Phan, L.4
Swerdlow, R.H.5
-
8
-
-
0031574362
-
Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging
-
Barrientos A, Casademont J, Cardellach F, Estivill X, Urbano-Arquez A, and Nunes V. Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging. Brain Res Mol Brain Res 52: 284-289, 1997.
-
(1997)
Brain Res Mol Brain Res
, vol.52
, pp. 284-289
-
-
Barrientos, A.1
Casademont, J.2
Cardellach, F.3
Estivill, X.4
Urbano-Arquez, A.5
Nunes, V.6
-
9
-
-
25444474703
-
Mitochondria take center stage in aging and neurodegeneration
-
Beal MF. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58: 495-505, 2005.
-
(2005)
Ann Neurol
, vol.58
, pp. 495-505
-
-
Beal, M.F.1
-
10
-
-
0032413244
-
Mitochondrial aging: Open questions
-
Beckman KB and Ames BN. Mitochondrial aging: Open questions. Ann NY Acad Sci 854: 118-127, 1998.
-
(1998)
Ann NY Acad Sci
, vol.854
, pp. 118-127
-
-
Beckman, K.B.1
Ames, B.N.2
-
11
-
-
0031916984
-
The free radical theory of aging matures
-
Beckman KB and Ames BN. The free radical theory of aging matures. Physiologic Rev 78: 548-581, 1998.
-
(1998)
Physiologic Rev
, vol.78
, pp. 548-581
-
-
Beckman, K.B.1
Ames, B.N.2
-
12
-
-
33749835508
-
Creatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial
-
Bender A, Kock W, Elstner M, Schombacher Y, Bender J, Moeschl M, Gekeler F, Muller-Myhsok B, Gasser T, Tatsch K, and Klopstock T. Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial. Neurology 67: 1262-1264, 2006.
-
(2006)
Neurology
, vol.67
, pp. 1262-1264
-
-
Bender, A.1
Kock, W.2
Elstner, M.3
Schombacher, Y.4
Bender, J.5
Moeschl, M.6
Gekeler, F.7
Muller-Myhsok, B.8
Gasser, T.9
Tatsch, K.10
Klopstock, T.11
-
13
-
-
0033681149
-
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
-
Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, and Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306, 2000.
-
(2000)
Nat Neurosci
, vol.3
, pp. 1301-1306
-
-
Betarbet, R.1
Sherer, T.B.2
MacKenzie, G.3
Garcia-Osuna, M.4
Panov, A.V.5
Greenamyre, J.T.6
-
14
-
-
0024334283
-
Mitochondrial function in Parkinson's disease
-
Bindoff LA, Birch-Machin M, Cartlidge NEF, Parker WD Jr, and Turnbull DM. Mitochondrial function in Parkinson's disease. Lancet 2: 49, 1989.
-
(1989)
Lancet
, vol.2
, pp. 49
-
-
Bindoff, L.A.1
Birch-Machin, M.2
Cartlidge, N.E.F.3
Parker Jr, W.D.4
Turnbull, D.M.5
-
15
-
-
17844385363
-
Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo
-
Bogacka I, Xie H, Bray GA, and Smith SR. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54: 1392-1399, 2005.
-
(2005)
Diabetes
, vol.54
, pp. 1392-1399
-
-
Bogacka, I.1
Xie, H.2
Bray, G.A.3
Smith, S.R.4
-
16
-
-
0034914927
-
Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients
-
Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, Richard-Harston S, Decamps A, Reignier B, Emariau JP, and Rainfray M. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Aging 30: 235-241, 2001.
-
(2001)
Age Aging
, vol.30
, pp. 235-241
-
-
Bourdel-Marchasson, I.1
Delmas-Beauvieux, M.C.2
Peuchant, E.3
Richard-Harston, S.4
Decamps, A.5
Reignier, B.6
Emariau, J.P.7
Rainfray, M.8
-
17
-
-
0028936986
-
Bioenergetic and oxidative stress in neurodegenerative diseases
-
Bowling AC and Beal MF. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci 56: 1151-1171, 1995.
-
(1995)
Life Sci
, vol.56
, pp. 1151-1171
-
-
Bowling, A.C.1
Beal, M.F.2
-
18
-
-
0021883670
-
Regional mitochondrial respiratory activity in Huntington's disease brain
-
Brennan WA, Bird ED, and Aprille JR. Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 44: 1948-1950, 1985.
-
(1985)
J Neurochem
, vol.44
, pp. 1948-1950
-
-
Brennan, W.A.1
Bird, E.D.2
Aprille, J.R.3
-
19
-
-
0035042470
-
Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA)
-
Brown AM, Sheu, RK, Mohs R, Haroutunian V, and Blass JP. Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA). J Mol Neurosci 16: 41-18, 2001.
-
(2001)
J Mol Neurosci
, vol.16
, pp. 41-18
-
-
Brown, A.M.1
Sheu, R.K.2
Mohs, R.3
Haroutunian, V.4
Blass, J.P.5
-
20
-
-
0030919567
-
Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
-
Browne SE, Bowling AD, MacGarvey U, Baik MJ, Berger SC, Muqit MMK, Bird ED, and Beal MF. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 41: 646-653, 1997.
-
(1997)
Ann Neurol
, vol.41
, pp. 646-653
-
-
Browne, S.E.1
Bowling, A.D.2
MacGarvey, U.3
Baik, M.J.4
Berger, S.C.5
Muqit, M.M.K.6
Bird, E.D.7
Beal, M.F.8
-
21
-
-
33947675275
-
Oxidative damage in Huntington's disease pathogenesis
-
Browne SE and Beal MF. Oxidative damage in Huntington's disease pathogenesis. Antioxid Redox Signal 8: 2061-2073, 2006.
-
(2006)
Antioxid Redox Signal
, vol.8
, pp. 2061-2073
-
-
Browne, S.E.1
Beal, M.F.2
-
22
-
-
0026663037
-
A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis
-
Brunk UT, Jones CB, and Sohal RS. A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis. Mutat Res 275: 395-103, 1992.
-
(1992)
Mutat Res
, vol.275
, pp. 395-103
-
-
Brunk, U.T.1
Jones, C.B.2
Sohal, R.S.3
-
23
-
-
0033796250
-
Mitochondrial free radical generation, oxidative stress, and aging
-
Cadenas E and Davies KJA. Mitochondrial free radical generation, oxidative stress, and aging. Free Rad Biol Med 29: 222-230, 2000.
-
(2000)
Free Rad Biol Med
, vol.29
, pp. 222-230
-
-
Cadenas, E.1
Davies, K.J.A.2
-
24
-
-
25144514232
-
Somatic mitochondrial DNA mutations in single neurons and glia
-
Cantuti-Castelvetri I, Lin MT, Zheng K, Keller-McGandy CE, Betensky RA, Johns DR, Beal MF, Standaert DG, and Simon DK. Somatic mitochondrial DNA mutations in single neurons and glia. Neurobiol Aging 26: 1343-1355, 2005.
-
(2005)
Neurobiol Aging
, vol.26
, pp. 1343-1355
-
-
Cantuti-Castelvetri, I.1
Lin, M.T.2
Zheng, K.3
Keller-McGandy, C.E.4
Betensky, R.A.5
Johns, D.R.6
Beal, M.F.7
Standaert, D.G.8
Simon, D.K.9
-
25
-
-
0032511186
-
Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease
-
Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, Durr A, Fontaine B, and Ballabio A. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93: 973-983, 1998.
-
(1998)
Cell
, vol.93
, pp. 973-983
-
-
Casari, G.1
De Fusco, M.2
Ciarmatori, S.3
Zeviani, M.4
Mora, M.5
Fernandez, P.6
De Michele, G.7
Filla, A.8
Cocozza, S.9
Marconi, R.10
Durr, A.11
Fontaine, B.12
Ballabio, A.13
-
26
-
-
33744963360
-
Tissue-specific effect of age and caloric restriction diet on mitochondrial DNA content
-
Cassano P, Sciancalepore AG, Lezza AMS, Leeuwenburgh C, Cantatore P, and Gadaleta MN. Tissue-specific effect of age and caloric restriction diet on mitochondrial DNA content. Rejuvenation Res 9: 211-214, 2006.
-
(2006)
Rejuvenation Res
, vol.9
, pp. 211-214
-
-
Cassano, P.1
Sciancalepore, A.G.2
Lezza, A.M.S.3
Leeuwenburgh, C.4
Cantatore, P.5
Gadaleta, M.N.6
-
27
-
-
0031455734
-
Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease
-
Cassarino DS, Fall CP, Swerdlow RH, Smith TS, Halvorsen EM, Miller SW, Parks JP, Parker WD Jr, and Bennett JP Jr. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim Biophys Acta 1362: 77-86, 1997.
-
(1997)
Biochim Biophys Acta
, vol.1362
, pp. 77-86
-
-
Cassarino, D.S.1
Fall, C.P.2
Swerdlow, R.H.3
Smith, T.S.4
Halvorsen, E.M.5
Miller, S.W.6
Parks, J.P.7
Parker Jr, W.D.8
Bennett Jr., J.P.9
-
28
-
-
0029871412
-
Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of the Alzheimer's type - place of the extracellular glutathione peroxidase
-
Ceballos-Picot I, Merad-Boudia M, Nicole A, Thevenin M, Hellier G, Legrain S, and Berr C. Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of the Alzheimer's type - place of the extracellular glutathione peroxidase. Free Radic Biol Med 20: 579-587, 1996.
-
(1996)
Free Radic Biol Med
, vol.20
, pp. 579-587
-
-
Ceballos-Picot, I.1
Merad-Boudia, M.2
Nicole, A.3
Thevenin, M.4
Hellier, G.5
Legrain, S.6
Berr, C.7
-
29
-
-
28844466919
-
How is mitochondrial biogenesis affected in mitochondrial disease
-
Chabi B, Adhihetty PJ, Ljubicic V, Hood DA. How is mitochondrial biogenesis affected in mitochondrial disease. Med Sci Sports Exercise 37: 2102-2110, 2005.
-
(2005)
Med Sci Sports Exercise
, vol.37
, pp. 2102-2110
-
-
Chabi, B.1
Adhihetty, P.J.2
Ljubicic, V.3
Hood, D.A.4
-
30
-
-
0033516529
-
Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population
-
Chagnon P, Gee M, Filion M, Robitaille Y, Belouchi M, and Gauvreau D. Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am J Med Genet 85: 20-30, 1999.
-
(1999)
Am J Med Genet
, vol.85
, pp. 20-30
-
-
Chagnon, P.1
Gee, M.2
Filion, M.3
Robitaille, Y.4
Belouchi, M.5
Gauvreau, D.6
-
31
-
-
0028199881
-
Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease
-
Chandrasekaran K, Giordano T, Brady DR, Stoll J, Martin LJ, and Rapoport SI. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res Mol Brain Res 24: 336-340, 1994.
-
(1994)
Brain Res Mol Brain Res
, vol.24
, pp. 336-340
-
-
Chandrasekaran, K.1
Giordano, T.2
Brady, D.R.3
Stoll, J.4
Martin, L.J.5
Rapoport, S.I.6
-
32
-
-
3543141113
-
Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release
-
Choo YS, Johnson GV, MacDonald M, Detloff PJ, and Lesort M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet 13: 1407-1420, 2004.
-
(2004)
Hum Mol Genet
, vol.13
, pp. 1407-1420
-
-
Choo, Y.S.1
Johnson, G.V.2
MacDonald, M.3
Detloff, P.J.4
Lesort, M.5
-
33
-
-
0027017232
-
Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age
-
Corral-Debrinksi M, Horton T, Lott MT, Shoffner JM, Beal MF, and Wallace DC. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 2: 324-329, 1992.
-
(1992)
Nat Genet
, vol.2
, pp. 324-329
-
-
Corral-Debrinksi, M.1
Horton, T.2
Lott, M.T.3
Shoffner, J.M.4
Beal, M.F.5
Wallace, D.C.6
-
34
-
-
3242668604
-
Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication
-
Coskun PE, Beal MF, and Wallace DC. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA 101: 10726-10731, 2004.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 10726-10731
-
-
Coskun, P.E.1
Beal, M.F.2
Wallace, D.C.3
-
35
-
-
33845468713
-
Insulin resistance syndrome and Alzheimer disease: Pathophysiologic mechanisms and therapeutic implications
-
Craft S. Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications. Alzheimer Dis Assoc Disord 20: 298-301, 2006.
-
(2006)
Alzheimer Dis Assoc Disord
, vol.20
, pp. 298-301
-
-
Craft, S.1
-
36
-
-
33749042331
-
Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
-
Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, and Krainc D. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127: 59-69, 2006.
-
(2006)
Cell
, vol.127
, pp. 59-69
-
-
Cui, L.1
Jeong, H.2
Borovecki, F.3
Parkhurst, C.N.4
Tanese, N.5
Krainc, D.6
-
37
-
-
0031585485
-
Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients
-
Curti D, Rognoni F, Gasparini L, Cattaneo A, Paolillo M, Racchi M, Zani L, Vianchetti A, Trabucchi M, Bergamaschi S, and Govoni S. Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients. Neurosci Lett 236: 13-16, 1997.
-
(1997)
Neurosci Lett
, vol.236
, pp. 13-16
-
-
Curti, D.1
Rognoni, F.2
Gasparini, L.3
Cattaneo, A.4
Paolillo, M.5
Racchi, M.6
Zani, L.7
Vianchetti, A.8
Trabucchi, M.9
Bergamaschi, S.10
Govoni, S.11
-
38
-
-
12644257598
-
-
Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, and Parker WD Jr. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci USA 94: 4526-4531, 1997.
-
Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, and Parker WD Jr. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci USA 94: 4526-4531, 1997.
-
-
-
-
39
-
-
0029979860
-
Human aging brain disorders: Role of antioxidant enzymes
-
De la Torre MR, Casado A, Lopez-Fernandez ME, Carrascosa D, Casado MC, Venarucci D, and Venarucci V. Human aging brain disorders: Role of antioxidant enzymes. Neurochem Res 21: 885-888, 1996.
-
(1996)
Neurochem Res
, vol.21
, pp. 885-888
-
-
De la Torre, M.R.1
Casado, A.2
Lopez-Fernandez, M.E.3
Carrascosa, D.4
Casado, M.C.5
Venarucci, D.6
Venarucci, V.7
-
40
-
-
0037458729
-
Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes
-
Dello Russo C, Gavrilyuk V, Weinberg G, Almeida A, Bolanos JP, Palmer J, Pelligrino D, Galea E, and Feinstein DL. Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes. J Biol Chem 278: 5823-5836, 2003.
-
(2003)
J Biol Chem
, vol.278
, pp. 5823-5836
-
-
Dello Russo, C.1
Gavrilyuk, V.2
Weinberg, G.3
Almeida, A.4
Bolanos, J.P.5
Palmer, J.6
Pelligrino, D.7
Galea, E.8
Feinstein, D.L.9
-
41
-
-
0024585155
-
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
-
Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, and Marsden CD. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381-389, 1989.
-
(1989)
J Neurochem
, vol.52
, pp. 381-389
-
-
Dexter, D.T.1
Carter, C.J.2
Wells, F.R.3
Javoy-Agid, F.4
Agid, Y.5
Lees, A.6
Jenner, P.7
Marsden, C.D.8
-
42
-
-
0031985802
-
Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes
-
Digby JE, Montague CT, Sewter CP, Sanders L, Wilkison WO, O'Rahilly S, and Prins JB. Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes. Diabetes 47: 138-141, 1998.
-
(1998)
Diabetes
, vol.47
, pp. 138-141
-
-
Digby, J.E.1
Montague, C.T.2
Sewter, C.P.3
Sanders, L.4
Wilkison, W.O.5
O'Rahilly, S.6
Prins, J.B.7
-
43
-
-
0037178573
-
Dietary intake of antioxidants and risk of Alzheimer disease
-
Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, and Breteler MM. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287: 3223-3229, 2002.
-
(2002)
JAMA
, vol.287
, pp. 3223-3229
-
-
Engelhart, M.J.1
Geerlings, M.I.2
Ruitenberg, A.3
van Swieten, J.C.4
Hofman, A.5
Witteman, J.C.6
Breteler, M.M.7
-
44
-
-
19344362520
-
Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: A meta-analysis
-
Etminan M, Gill SS, and Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis. Lancet Neurol 4: 362-365, 2005.
-
(2005)
Lancet Neurol
, vol.4
, pp. 362-365
-
-
Etminan, M.1
Gill, S.S.2
Samii, A.3
-
45
-
-
0020003044
-
18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomography study of senile dementia
-
Farkas T, Ferris SH, Wolf AP, de Leon MJ, Christman DR, Reisberg B, Alavi A, Fowler JS, George AE, and Reivich M. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomography study of senile dementia. Am J Psychiatry 139: 352-353, 1982.
-
(1982)
Am J Psychiatry
, vol.139
, pp. 352-353
-
-
Farkas, T.1
Ferris, S.H.2
Wolf, A.P.3
de Leon, M.J.4
Christman, D.R.5
Reisberg, B.6
Alavi, A.7
Fowler, J.S.8
George, A.E.9
Reivich, M.10
-
46
-
-
33645116252
-
Genetics of Parkinson disease: Paradigm shifts and future prospects
-
Farrer MJ. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7: 306-318, 2006.
-
(2006)
Nat Rev Genet
, vol.7
, pp. 306-318
-
-
Farrer, M.J.1
-
47
-
-
0029988363
-
Assessment of coenzyme Q10 tolerability in Huntington's disease
-
Feigin A, Kieburtz K, Como P, Hickey C, Clause K, Abwender D, Zimmerman C, Steinberg K, and Shoulson I. Assessment of coenzyme Q10 tolerability in Huntington's disease. Mov Disord 11: 321-323, 1996.
-
(1996)
Mov Disord
, vol.11
, pp. 321-323
-
-
Feigin, A.1
Kieburtz, K.2
Como, P.3
Hickey, C.4
Clause, K.5
Abwender, D.6
Zimmerman, C.7
Steinberg, K.8
Shoulson, I.9
-
48
-
-
20444497357
-
Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?
-
Feinstein DL, Spagnolo A, Akar C, Weinberg G, Murphy P, Gavrilyuk V, and Dello Russo C. Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key? Biochemical Pharmacology 70: 177-188, 2005.
-
(2005)
Biochemical Pharmacology
, vol.70
, pp. 177-188
-
-
Feinstein, D.L.1
Spagnolo, A.2
Akar, C.3
Weinberg, G.4
Murphy, P.5
Gavrilyuk, V.6
Dello Russo, C.7
-
49
-
-
10244264754
-
Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress
-
Fiskum G, Rosenthal RE, Vereczki V, Martin E, Hoffman GE, Chinopoulos C, and Kowaltowski A. Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress. J Bioenerg Biomembr 36: 347-352, 2004.
-
(2004)
J Bioenerg Biomembr
, vol.36
, pp. 347-352
-
-
Fiskum, G.1
Rosenthal, R.E.2
Vereczki, V.3
Martin, E.4
Hoffman, G.E.5
Chinopoulos, C.6
Kowaltowski, A.7
-
50
-
-
0022466381
-
Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys
-
Forno LS, Langston JW, DeLanney LE, Irwin I, and Ricuarte GA. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol 20: 449-155, 1986.
-
(1986)
Ann Neurol
, vol.20
, pp. 449-155
-
-
Forno, L.S.1
Langston, J.W.2
DeLanney, L.E.3
Irwin, I.4
Ricuarte, G.A.5
-
51
-
-
24644468116
-
LRRK2: Both a cause and a risk factor for Parkinson disease?
-
Foroud T. LRRK2: both a cause and a risk factor for Parkinson disease? Neurology 65: 664-665, 2005.
-
(2005)
Neurology
, vol.65
, pp. 664-665
-
-
Foroud, T.1
-
52
-
-
0020518539
-
Alzheimer's disease: Focal cortical changes shown by positron emission tomography
-
Foster NL, Chase TN, Fedio P, Patronas MJ, Brooks RA, and Di Chiro G. Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology 33: 961-965, 1983.
-
(1983)
Neurology
, vol.33
, pp. 961-965
-
-
Foster, N.L.1
Chase, T.N.2
Fedio, P.3
Patronas, M.J.4
Brooks, R.A.5
Di Chiro, G.6
-
53
-
-
0019783428
-
A clinical and physiological study with oxygen-15 and positron tomography
-
Frackowiak RSJ, Pozzilli C, Legg NJ, Du Boulay GH, Marshall J, Lenzi GL, and Jones T. A clinical and physiological study with oxygen-15 and positron tomography. Brain 104: 753-778, 1981.
-
(1981)
Brain
, vol.104
, pp. 753-778
-
-
Frackowiak, R.S.J.1
Pozzilli, C.2
Legg, N.J.3
Du Boulay, G.H.4
Marshall, J.5
Lenzi, G.L.6
Jones, T.7
-
54
-
-
3342978711
-
Enzyme histochemical studies of senile plaques
-
Friede RI. Enzyme histochemical studies of senile plaques. J Neuropathol Exp Neurol 24: 477-191, 1965.
-
(1965)
J Neuropathol Exp Neurol
, vol.24
, pp. 477-191
-
-
Friede, R.I.1
-
55
-
-
0020594056
-
Regional cerebral metabolic alterations in dementia of the Alzheimer type: Positron emission tomography with [18F]fluorodeoxyglucose
-
Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Huesman RH, and Derenzo SE, et al. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr 7: 590-598, 1983.
-
(1983)
J Comput Assist Tomogr
, vol.7
, pp. 590-598
-
-
Friedland, R.P.1
Budinger, T.F.2
Ganz, E.3
Yano, Y.4
Mathis, C.A.5
Koss, B.6
Ober, B.A.7
Huesman, R.H.8
Derenzo, S.E.9
-
56
-
-
0032181128
-
Aging and mitochondria
-
Gadaleta MN, Cormio A, Pesce V, Lezza AM, and Cantatore. Aging and mitochondria. Biochimie 80: 863-870, 1998.
-
(1998)
Biochimie
, vol.80
, pp. 863-870
-
-
Gadaleta, M.N.1
Cormio, A.2
Pesce, V.3
Lezza, A.M.4
Cantatore5
-
57
-
-
34347337120
-
A double-blind, placebo controlled, 18 month pilot study of the PPAR-gamma agonist pioglitazone in Alzheimer's disease
-
Geldmacher DS, Fritsch T, McClendon MJ, Lerner AJ, and Landreth GE. A double-blind, placebo controlled, 18 month pilot study of the PPAR-gamma agonist pioglitazone in Alzheimer's disease. Alzheimer's Dementia 2(Supplement): S366, 2006.
-
(2006)
Alzheimer's Dementia
, vol.2
, Issue.SUPPL.EMENT
-
-
Geldmacher, D.S.1
Fritsch, T.2
McClendon, M.J.3
Lerner, A.J.4
Landreth, G.E.5
-
58
-
-
34347346156
-
The thiazolidinedione pioglitazone alters mitochondrial function in human neuronal-like cells
-
Ghosh S, Patel N, Rahn K, McAllister J, Sadeghi S, Horwitz G, Berry D, Wang KX, and Swerdlow RH. The thiazolidinedione pioglitazone alters mitochondrial function in human neuronal-like cells. Mol Pharmacol 71: 1695-1702, 2007.
-
(2007)
Mol Pharmacol
, vol.71
, pp. 1695-1702
-
-
Ghosh, S.1
Patel, N.2
Rahn, K.3
McAllister, J.4
Sadeghi, S.5
Horwitz, G.6
Berry, D.7
Wang, K.X.8
Swerdlow, R.H.9
-
60
-
-
0023732664
-
Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease
-
Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, Harding B, and Perrino P. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol 45: 836-840, 1988.
-
(1988)
Arch Neurol
, vol.45
, pp. 836-840
-
-
Gibson, G.E.1
Sheu, K.F.2
Blass, J.P.3
Baker, A.4
Carlson, K.C.5
Harding, B.6
Perrino, P.7
-
61
-
-
33846654677
-
Huntington's disease-making connections
-
Greenamyre JT. Huntington's disease-making connections. N Engl J Med 356: 518-520, 2007.
-
(2007)
N Engl J Med
, vol.356
, pp. 518-520
-
-
Greenamyre, J.T.1
-
62
-
-
0029875381
-
Mitochondrial defect in Huntington's disease caudate nucleus
-
Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, and Schapira AHV. Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 39: 385-389, 1996.
-
(1996)
Ann Neurol
, vol.39
, pp. 385-389
-
-
Gu, M.1
Gash, M.T.2
Mann, V.M.3
Javoy-Agid, F.4
Cooper, J.M.5
Schapira, A.H.V.6
-
63
-
-
0036830565
-
Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy
-
Guy J, Qi X, Pallotti F, Schon EA, Manfredi G, Carelli V, Martinuzzi A, Hauswirth WW, and Lewin AS. Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy. Ann Neurol 52: 534-542, 2002.
-
(2002)
Ann Neurol
, vol.52
, pp. 534-542
-
-
Guy, J.1
Qi, X.2
Pallotti, F.3
Schon, E.A.4
Manfredi, G.5
Carelli, V.6
Martinuzzi, A.7
Hauswirth, W.W.8
Lewin, A.S.9
-
64
-
-
85153980494
-
-
Hamblet NS, Ragland B, Ali M, Conyers B, and Castora FJ. Mutations in mitochondrial-encoded cytochrome c oxidase subunits I, II, and III genes detected in Alzheimer's disease using single-strand conformation polymorphism. Electrophoresis 27: 398-108, 2006.
-
Hamblet NS, Ragland B, Ali M, Conyers B, and Castora FJ. Mutations in mitochondrial-encoded cytochrome c oxidase subunits I, II, and III genes detected in Alzheimer's disease using single-strand conformation polymorphism. Electrophoresis 27: 398-108, 2006.
-
-
-
-
65
-
-
33845596500
-
Peroxisome proliferators-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism
-
Handschin C and Spiegelman BM. Peroxisome proliferators-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism Endocrine Rev 27: 728-735, 2006.
-
(2006)
Endocrine Rev
, vol.27
, pp. 728-735
-
-
Handschin, C.1
Spiegelman, B.M.2
-
66
-
-
0015319592
-
The biologic clock: The mitochondria?
-
Harmon D. The biologic clock: the mitochondria? J Am Geriatr Soc 20: 145-147, 1972.
-
(1972)
J Am Geriatr Soc
, vol.20
, pp. 145-147
-
-
Harmon, D.1
-
67
-
-
20144389286
-
Antioxidant treatment of patients with Friedreich ataxia: Four-year follow-up
-
Hart PE, Lodi R, Rajagopalan B, Bradely JL, Crilley JG, Turner C, Blamire AM, Manners D, Styles P, Schapira AH, and Cooper JM. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch Neurol 62: 621-626, 2005.
-
(2005)
Arch Neurol
, vol.62
, pp. 621-626
-
-
Hart, P.E.1
Lodi, R.2
Rajagopalan, B.3
Bradely, J.L.4
Crilley, J.G.5
Turner, C.6
Blamire, A.M.7
Manners, D.8
Styles, P.9
Schapira, A.H.10
Cooper, J.M.11
-
68
-
-
20444499367
-
Acute treatment with the PPARgamma agonist pioglitazone and Ibuprofen reduces glial inflammation and Abetal-42 levels in APPV717I transgenic mice
-
Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Klockgether T, and Van Leuven F. Acute treatment with the PPARgamma agonist pioglitazone and Ibuprofen reduces glial inflammation and Abetal-42 levels in APPV717I transgenic mice. Brain 128: 1442-1453, 2005.
-
(2005)
Brain
, vol.128
, pp. 1442-1453
-
-
Heneka, M.T.1
Sastre, M.2
Dumitrescu-Ozimek, L.3
Hanke, A.4
Dewachter, I.5
Klockgether, T.6
Van Leuven, F.7
-
69
-
-
0035341254
-
Mitochondrial abnormalities in Alzheimer's disease
-
Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, and Smith MA. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21: 3017-3023, 2001.
-
(2001)
J Neurosci
, vol.21
, pp. 3017-3023
-
-
Hirai, K.1
Aliev, G.2
Nunomura, A.3
Fujioka, H.4
Russell, R.L.5
Atwood, C.S.6
Johnson, A.B.7
Kress, Y.8
Vinters, H.V.9
Tabaton, M.10
Shimohama, S.11
Cash, A.D.12
Siedlak, S.L.13
Harris, P.L.14
Jones, P.K.15
Petersen, R.B.16
Perry, G.17
Smith, M.A.18
-
70
-
-
5344247243
-
Turbocharging mitochondria
-
Houten SM and Auwerx J. Turbocharging mitochondria. Cell 119: 5-7, 2004.
-
(2004)
Cell
, vol.119
, pp. 5-7
-
-
Houten, S.M.1
Auwerx, J.2
-
71
-
-
0024561803
-
Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with coenzyme Q10 and idebenone
-
Ihara Y, Namba R, Kuroda S, Sato T, and Shirabe T. Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone. J Neurol Sci 90: 263-271, 1989.
-
(1989)
J Neurol Sci
, vol.90
, pp. 263-271
-
-
Ihara, Y.1
Namba, R.2
Kuroda, S.3
Sato, T.4
Shirabe, T.5
-
72
-
-
20844450562
-
Mitochondrial DNA as a cancer biomarker
-
Jakupciak JP, Wang W, Markowitz ME, Ally D, Coble M, Srivastava S, Maitra A, Barker PE, Sidransky D, and O'Connell CD. Mitochondrial DNA as a cancer biomarker. J Mol Diagn 7: 258-267, 2005.
-
(2005)
J Mol Diagn
, vol.7
, pp. 258-267
-
-
Jakupciak, J.P.1
Wang, W.2
Markowitz, M.E.3
Ally, D.4
Coble, M.5
Srivastava, S.6
Maitra, A.7
Barker, P.E.8
Sidransky, D.9
O'Connell, C.D.10
-
73
-
-
0026772294
-
Serum antioxidant enzyme activity in Parkinson's disease
-
Kalra J, Rajput AH, Mantha SVV, and Prasad K. Serum antioxidant enzyme activity in Parkinson's disease. Mol Cell Biochem 110: 165-168, 1992.
-
(1992)
Mol Cell Biochem
, vol.110
, pp. 165-168
-
-
Kalra, J.1
Rajput, A.H.2
Mantha, S.V.V.3
Prasad, K.4
-
74
-
-
22044443172
-
Mitochondrial transcription factor A in the maintenance of mitochondrial DNA: Overview of its multiple roles
-
Kang D and Hamaski N. Mitochondrial transcription factor A in the maintenance of mitochondrial DNA: overview of its multiple roles. Ann NY Acad Sci 1042: 101-108, 2005.
-
(2005)
Ann NY Acad Sci
, vol.1042
, pp. 101-108
-
-
Kang, D.1
Hamaski, N.2
-
75
-
-
7844237506
-
Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression
-
Kelly LJ, Vicario PP, Thompson GM, Caldelore MR, Doebber TW, Ventre J, Wu MS, Meurer R, Forrest MJ, Conner MW, Cascieri MA, and Muller DE. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology 139: 4920-1927, 1998.
-
(1998)
Endocrinology
, vol.139
, pp. 4920-1927
-
-
Kelly, L.J.1
Vicario, P.P.2
Thompson, G.M.3
Caldelore, M.R.4
Doebber, T.W.5
Ventre, J.6
Wu, M.S.7
Meurer, R.8
Forrest, M.J.9
Conner, M.W.10
Cascieri, M.A.11
Muller, D.E.12
-
76
-
-
10244252759
-
Development of mitochondrial gene replacement therapy
-
Khan SM and Bennett JP Jr. Development of mitochondrial gene replacement therapy. J Bioenerg Biomembr 36: 387-393, 2004.
-
(2004)
J Bioenerg Biomembr
, vol.36
, pp. 387-393
-
-
Khan, S.M.1
Bennett Jr., J.P.2
-
78
-
-
1942486792
-
Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice
-
Kieran D, Kalmar B, Dick JR, Riddoch-Contreras J, Burnstock G, and Greensmith L. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat Med 10: 402-105, 2004.
-
(2004)
Nat Med
, vol.10
, pp. 402-105
-
-
Kieran, D.1
Kalmar, B.2
Dick, J.R.3
Riddoch-Contreras, J.4
Burnstock, G.5
Greensmith, L.6
-
79
-
-
33846504706
-
-
Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, and Gottesman MM. A silent polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525-528, 2007.
-
Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, and Gottesman MM. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525-528, 2007.
-
-
-
-
80
-
-
0022665705
-
Brain glutathione peroxidase in neurodegenerative disorders
-
Kish SJ, Morito CL, and Hornykiewicz O. Brain glutathione peroxidase in neurodegenerative disorders. Neurochem Pathol 4: 23-28, 1986.
-
(1986)
Neurochem Pathol
, vol.4
, pp. 23-28
-
-
Kish, S.J.1
Morito, C.L.2
Hornykiewicz, O.3
-
81
-
-
0026718966
-
Brain cytochrome oxidase in Alzheimer's disease
-
Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, Wilson JM, DiStefano LM, and Nobrega JN. Brain cytochrome oxidase in Alzheimer's disease. J Neurochem 59: 113-114, 1992.
-
(1992)
J Neurochem
, vol.59
, pp. 113-114
-
-
Kish, S.J.1
Bergeron, C.2
Rajput, A.3
Dozic, S.4
Mastrogiacomo, F.5
Chang, L.J.6
Wilson, J.M.7
DiStefano, L.M.8
Nobrega, J.N.9
-
82
-
-
33846588874
-
SNPs, silent but not invisible
-
Komar AA. SNPs, silent but not invisible. Science 315: 466-167, 2007.
-
(2007)
Science
, vol.315
, pp. 466-167
-
-
Komar, A.A.1
-
83
-
-
0030813487
-
Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin
-
Koutnikova H, Campuzano V, Foury F, Dolle P, Cazzalini O, and Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet 16: 345-351, 1997.
-
(1997)
Nat Genet
, vol.16
, pp. 345-351
-
-
Koutnikova, H.1
Campuzano, V.2
Foury, F.3
Dolle, P.4
Cazzalini, O.5
Koenig, M.6
-
84
-
-
0037287897
-
Mutation and intracellular clonal expansion of mitochondrial genomes: Two synergistic components of the aging process?
-
Kraytsberg Y, Nekhaeva E, Bodyak NB, and Khrapko K. Mutation and intracellular clonal expansion of mitochondrial genomes: two synergistic components of the aging process? Mech Ageing Dev 124: 49-53, 2003.
-
(2003)
Mech Ageing Dev
, vol.124
, pp. 49-53
-
-
Kraytsberg, Y.1
Nekhaeva, E.2
Bodyak, N.B.3
Khrapko, K.4
-
85
-
-
33646351299
-
Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons
-
Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, and Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 38: 518-520, 2006.
-
(2006)
Nat Genet
, vol.38
, pp. 518-520
-
-
Kraytsberg, Y.1
Kudryavtseva, E.2
McKee, A.C.3
Geula, C.4
Kowall, N.W.5
Khrapko, K.6
-
86
-
-
22344456832
-
Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging
-
Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, Morrow JD, Van Remmen H, Sedivy JM, Yamasoba T, Tanokura M, Weindruch R, Leeuwenburgh C, and Prolla TA. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309: 481-184, 2005.
-
(2005)
Science
, vol.309
, pp. 481-184
-
-
Kujoth, G.C.1
Hiona, A.2
Pugh, T.D.3
Someya, S.4
Panzer, K.5
Wohlgemuth, S.E.6
Hofer, T.7
Seo, A.Y.8
Sullivan, R.9
Jobling, W.A.10
Morrow, J.D.11
Van Remmen, H.12
Sedivy, J.M.13
Yamasoba, T.14
Tanokura, M.15
Weindruch, R.16
Leeuwenburgh, C.17
Prolla, T.A.18
-
87
-
-
0036331936
-
Endogenouos sodium-potassium ATPase inhibition related biochemical cascade in trisomy 21 and Huntington's disease: Neural regulation of genomic function
-
Kumar AR and Kurup PA. Endogenouos sodium-potassium ATPase inhibition related biochemical cascade in trisomy 21 and Huntington's disease: Neural regulation of genomic function. Neurology India 50: 174-180, 2002.
-
(2002)
Neurology India
, vol.50
, pp. 174-180
-
-
Kumar, A.R.1
Kurup, P.A.2
-
88
-
-
33644778845
-
Parkin enhances mitochondrial biogenesis in proliferating cells
-
Kuroda Y, Mitsui T, Kunishige M, Shono M, Akaike M, Azuma H, and Matsumoto T. Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet 15: 883-895, 2006.
-
(2006)
Hum Mol Genet
, vol.15
, pp. 883-895
-
-
Kuroda, Y.1
Mitsui, T.2
Kunishige, M.3
Shono, M.4
Akaike, M.5
Azuma, H.6
Matsumoto, T.7
-
89
-
-
33845399894
-
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
-
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliot P, Geny B, Laakso M, Puigserver P, and Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127: 1109-1122, 2006.
-
(2006)
Cell
, vol.127
, pp. 1109-1122
-
-
Lagouge, M.1
Argmann, C.2
Gerhart-Hines, Z.3
Meziane, H.4
Lerin, C.5
Daussin, F.6
Messadeq, N.7
Milne, J.8
Lambert, P.9
Elliot, P.10
Geny, B.11
Laakso, M.12
Puigserver, P.13
Auwerx, J.14
-
90
-
-
33745265189
-
PPAR? agonists as new therapeutic agents for the treatment of Alzheimer's disease
-
Landreth G. PPAR? agonists as new therapeutic agents for the treatment of Alzheimer's disease. Exp Neurol 199: 245-248, 2006.
-
(2006)
Exp Neurol
, vol.199
, pp. 245-248
-
-
Landreth, G.1
-
91
-
-
0020680904
-
Chronic parkinsonism in humans due to a product of meperidine-analog synthesis
-
Langston JW, Ballard PA, Tetrud JW, and Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979-980, 1983.
-
(1983)
Science
, vol.219
, pp. 979-980
-
-
Langston, J.W.1
Ballard, P.A.2
Tetrud, J.W.3
Irwin, I.4
-
92
-
-
2342608923
-
Midlife dietary intake of antioxidants and risk of late-life incident dementia: The Honolulu-Asia Aging Study
-
Laurin D, Masaki KH, Foley DJ, White LR, and Launer LJ. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol 159: 959-967, 2004.
-
(2004)
Am J Epidemiol
, vol.159
, pp. 959-967
-
-
Laurin, D.1
Masaki, K.H.2
Foley, D.J.3
White, L.R.4
Launer, L.J.5
-
93
-
-
13444271923
-
Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress
-
Lee HC and Wei YH. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol 37: 822-834, 2005.
-
(2005)
Int J Biochem Cell Biol
, vol.37
, pp. 822-834
-
-
Lee, H.C.1
Wei, Y.H.2
-
94
-
-
28944446431
-
The many faces of PPARgamma
-
Lehrke M and Lazar MA. The many faces of PPARgamma. Cell 123: 993-999, 2005.
-
(2005)
Cell
, vol.123
, pp. 993-999
-
-
Lehrke, M.1
Lazar, M.A.2
-
95
-
-
18344366874
-
Role of mitochondria in oxidative stress and aging
-
Lenaz G, Bovina C, D'Aurelio M, Fato R, Formiggini G, Genova ML, Giuliano G, Pich MM, Paolucci U, Castelli GP, and Ventura B. Role of mitochondria in oxidative stress and aging. Ann NY Acad Sci 959: 199-213, 2002.
-
(2002)
Ann NY Acad Sci
, vol.959
, pp. 199-213
-
-
Lenaz, G.1
Bovina, C.2
D'Aurelio, M.3
Fato, R.4
Formiggini, G.5
Genova, M.L.6
Giuliano, G.7
Pich, M.M.8
Paolucci, U.9
Castelli, G.P.10
Ventura, B.11
-
96
-
-
0037081814
-
High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain
-
Lin MT, Simon DK, Ahn CH, Kim LM, and Beal MF. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum Mol Genet 11: 133-145, 2002.
-
(2002)
Hum Mol Genet
, vol.11
, pp. 133-145
-
-
Lin, M.T.1
Simon, D.K.2
Ahn, C.H.3
Kim, L.M.4
Beal, M.F.5
-
97
-
-
0024541837
-
Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases
-
Linnane AW, Marzuki S, Ozawa T, and Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1: 642-645, 1989.
-
(1989)
Lancet
, vol.1
, pp. 642-645
-
-
Linnane, A.W.1
Marzuki, S.2
Ozawa, T.3
Tanaka, M.4
-
98
-
-
0029073455
-
Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease
-
Lovell MA, Ehmann WD, Butler SM, and Markesbery WR. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45: 1594-1601, 1995.
-
(1995)
Neurology
, vol.45
, pp. 1594-1601
-
-
Lovell, M.A.1
Ehmann, W.D.2
Butler, S.M.3
Markesbery, W.R.4
-
99
-
-
0037320324
-
Antioxidant vitamin intake and risk of Alzheimer disease
-
Luchsinger JA, Tang MX, Shea S, and Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 60: 203-208, 2003.
-
(2003)
Arch Neurol
, vol.60
, pp. 203-208
-
-
Luchsinger, J.A.1
Tang, M.X.2
Shea, S.3
Mayeux, R.4
-
100
-
-
0028558576
-
The development of mitochondrial medicine
-
Luft R. The development of mitochondrial medicine. Proc Natl Acad Sci USA 91: 8731-8738, 1994.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 8731-8738
-
-
Luft, R.1
-
101
-
-
0032568610
-
Localization of the Wilson's disease protein product to mitochondria
-
Lutsenko O and Cooper MJ. Localization of the Wilson's disease protein product to mitochondria. Proc Natl Acad Sci USA 95: 6004-6009, 1998.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 6004-6009
-
-
Lutsenko, O.1
Cooper, M.J.2
-
102
-
-
0027273072
-
Disorders of movement in Leigh syndrome
-
Macaya A, Munell F, Burke RE, and De Vivo DC. Disorders of movement in Leigh syndrome. Neuropediatrics 24: 60-67, 1993.
-
(1993)
Neuropediatrics
, vol.24
, pp. 60-67
-
-
Macaya, A.1
Munell, F.2
Burke, R.E.3
De Vivo, D.C.4
-
103
-
-
2342628596
-
Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: Implications for early mitochondrial dysfunction and oxidative damage
-
Manczak M, Park BS, Jung Y, and Reddy PH. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Med 5: 147-162, 2004.
-
(2004)
Neuromolecular Med
, vol.5
, pp. 147-162
-
-
Manczak, M.1
Park, B.S.2
Jung, Y.3
Reddy, P.H.4
-
104
-
-
13244292394
-
Time-course of mitochondrial gene expressions in mice brains: Implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging
-
Manczak M, Jung Y, Park BS, Partovi D, and Reddy PH. Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging. J Neurochem 92: 494-504, 2005.
-
(2005)
J Neurochem
, vol.92
, pp. 494-504
-
-
Manczak, M.1
Jung, Y.2
Park, B.S.3
Partovi, D.4
Reddy, P.H.5
-
105
-
-
1542283630
-
Peroxisome proliferator-activated receptor alpha target genes
-
Mandred S, Muller M, and Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 61: 393-116, 2004.
-
(2004)
Cell Mol Life Sci
, vol.61
, pp. 393-116
-
-
Mandred, S.1
Muller, M.2
Kersten, S.3
-
106
-
-
0032031780
-
Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease
-
Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, and Freedman ML. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 150: 40-44, 1998.
-
(1998)
Exp Neurol
, vol.150
, pp. 40-44
-
-
Marcus, D.L.1
Thomas, C.2
Rodriguez, C.3
Simberkoff, K.4
Tsai, J.S.5
Strafaci, J.A.6
Freedman, M.L.7
-
107
-
-
0032902974
-
Oxidative alterations in Alzheimer's disease
-
Markesbery WR and Carney JM. Oxidative alterations in Alzheimer's disease. Brain Pathol 9: 133-146, 1999.
-
(1999)
Brain Pathol
, vol.9
, pp. 133-146
-
-
Markesbery, W.R.1
Carney, J.M.2
-
108
-
-
0023766185
-
Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus
-
Marttila RJ, Lorentz H, and Rinne UK. Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J Neurol Sci 86: 321-331, 1988.
-
(1988)
J Neurol Sci
, vol.86
, pp. 321-331
-
-
Marttila, R.J.1
Lorentz, H.2
Rinne, U.K.3
-
110
-
-
0033912405
-
Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging
-
Melov S. Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging. Ann NY Acad Sci 908: 219-225, 2000.
-
(2000)
Ann NY Acad Sci
, vol.908
, pp. 219-225
-
-
Melov, S.1
-
111
-
-
0033595684
-
Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication
-
Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, and Attardi G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286: 774-779, 1999.
-
(1999)
Science
, vol.286
, pp. 774-779
-
-
Michikawa, Y.1
Mazzucchelli, F.2
Bresolin, N.3
Scarlato, G.4
Attardi, G.5
-
112
-
-
0019160038
-
Mitochondrial role in cell aging
-
Miquel J, Economos AD, Fleming J, and Johnson JE. Mitochondrial role in cell aging. Exp Gerontol 15: 575-591, 1980.
-
(1980)
Exp Gerontol
, vol.15
, pp. 575-591
-
-
Miquel, J.1
Economos, A.D.2
Fleming, J.3
Johnson, J.E.4
-
113
-
-
0024330311
-
Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease
-
Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, and Kagawa Y. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Comm 163: 1450-1455, 1989.
-
(1989)
Biochem Biophys Res Comm
, vol.163
, pp. 1450-1455
-
-
Mizuno, Y.1
Ohta, S.2
Tanaka, M.3
Takamiya, S.4
Suzuki, K.5
Sato, T.6
Oya, H.7
Ozawa, T.8
Kagawa, Y.9
-
114
-
-
0026718556
-
The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): Genetic, biochemical, and morphological correlations in skeletal muscle
-
Moraes CT, Ricci E, Bonilla E, DiMauro S, and Schon EA. The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am J Hum Genet 50: 934-949, 1992.
-
(1992)
Am J Hum Genet
, vol.50
, pp. 934-949
-
-
Moraes, C.T.1
Ricci, E.2
Bonilla, E.3
DiMauro, S.4
Schon, E.A.5
-
115
-
-
33845899137
-
Human catechol-0-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure
-
Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, and Diatchenko L. Human catechol-0-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314: 1930-1932, 2006.
-
(2006)
Science
, vol.314
, pp. 1930-1932
-
-
Nackley, A.G.1
Shabalina, S.A.2
Tchivileva, I.E.3
Satterfield, K.4
Korchynskyi, O.5
Makarov, S.S.6
Maixner, W.7
Diatchenko, L.8
-
116
-
-
33847059997
-
The mitochondrial energy transduction system and the aging process
-
Navarro A and Boveris AA. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 292: C670-686, 2007.
-
(2007)
Am J Physiol Cell Physiol
, vol.292
-
-
Navarro, A.1
Boveris, A.A.2
-
117
-
-
0037117576
-
Clonally expanded mtDNA point mutations are abundant in individual cells of human tissues
-
Nekhaeva E, Bodyak ND, Kraytsberg Y, McGrath SB, Van Orsouw, Pluzhnikov A, Wei JY, Vijg J, and Khrapko K. Clonally expanded mtDNA point mutations are abundant in individual cells of human tissues. Proc Natl Acad Sci USA 99: 5521-5526, 2002.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 5521-5526
-
-
Nekhaeva, E.1
Bodyak, N.D.2
Kraytsberg, Y.3
McGrath, S.B.4
Orsouw, V.5
Pluzhnikov, A.6
Wei, J.Y.7
Vijg, J.8
Khrapko, K.9
-
118
-
-
0021810979
-
-
Nicklas WJ, Vyas I, and Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 36: 2503-2508, 1985.
-
Nicklas WJ, Vyas I, and Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 36: 2503-2508, 1985.
-
-
-
-
119
-
-
33645894705
-
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease
-
NINDS NET-PD Investigators
-
NINDS NET-PD Investigators. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology 66: 664-671, 2006.
-
(2006)
Neurology
, vol.66
, pp. 664-671
-
-
-
120
-
-
26844558334
-
Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS
-
Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, Tedesco L, Falcone S, Valerio A, Cantoni O, Clementi E, Moncada S, and Carruba MO. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310: 314-317, 2005.
-
(2005)
Science
, vol.310
, pp. 314-317
-
-
Nisoli, E.1
Tonello, C.2
Cardile, A.3
Cozzi, V.4
Bracale, R.5
Tedesco, L.6
Falcone, S.7
Valerio, A.8
Cantoni, O.9
Clementi, E.10
Moncada, S.11
Carruba, M.O.12
-
121
-
-
0036327065
-
Early mitochondrial defects in Huntington's disease are a direct effect of polyglutamines
-
Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, and Greenamyre JT. Early mitochondrial defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci 5: 731-736, 2002.
-
(2002)
Nat Neurosci
, vol.5
, pp. 731-736
-
-
Panov, A.V.1
Gutekunst, C.A.2
Leavitt, B.R.3
Hayden, M.R.4
Burke, J.R.5
Strittmatter, W.J.6
Greenamyre, J.T.7
-
122
-
-
0024848034
-
Electron transport chain abnormalities in idiopathic Parkinson's disease
-
Parker WD, Boyson SJ, and Parks JK. Electron transport chain abnormalities in idiopathic Parkinson's disease. Ann Neurol 26: 719-723, 1989.
-
(1989)
Ann Neurol
, vol.26
, pp. 719-723
-
-
Parker, W.D.1
Boyson, S.J.2
Parks, J.K.3
-
123
-
-
0025024024
-
Cytochrome oxidase deficiency in Alzheimer's disease
-
Parker WD, Filley CM, and Parks JK. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40: 1302-1303, 1990.
-
(1990)
Neurology
, vol.40
, pp. 1302-1303
-
-
Parker, W.D.1
Filley, C.M.2
Parks, J.K.3
-
125
-
-
0025087726
-
Evidence for a defect in NADH:ubiquinone oxidoreductase (complex I) in Huntington's disease
-
Parker WD Jr, Boyson SJ, Luders AS, and Parks JK. Evidence for a defect in NADH:ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurology 40: 1231-1234, 1990.
-
(1990)
Neurology
, vol.40
, pp. 1231-1234
-
-
Parker Jr, W.D.1
Boyson, S.J.2
Luders, A.S.3
Parks, J.K.4
-
126
-
-
0029055772
-
Cytochrome c oxidase in Alzheimer's disease brain: Purification and characterization
-
Parker WD Jr and Parks JK. Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization. Neurology 45: 482-486, 1995.
-
(1995)
Neurology
, vol.45
, pp. 482-486
-
-
Parker Jr, W.D.1
Parks, J.K.2
-
127
-
-
10444243239
-
Mitochondrial ND5 mutations in idiopathic Parkinson's disease
-
Parker WD Jr and Parks JK. Mitochondrial ND5 mutations in idiopathic Parkinson's disease. Biochem Biophys Res Commun 326: 667-669, 2005.
-
(2005)
Biochem Biophys Res Commun
, vol.326
, pp. 667-669
-
-
Parker Jr, W.D.1
Parks, J.K.2
-
128
-
-
0027530638
-
Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. The Parkinson Study Group
-
Parkinson Study Group
-
Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. The Parkinson Study Group. N Engl J Med 328: 176-183, 1993.
-
(1993)
N Engl J Med
, vol.328
, pp. 176-183
-
-
-
129
-
-
0020308323
-
Parkinson's disease: A disorder due to nigral glutathione deficiency?
-
Perry TL, Godin DV, and Hansen S. Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33: 305-310, 1982.
-
(1982)
Neurosci Lett
, vol.33
, pp. 305-310
-
-
Perry, T.L.1
Godin, D.V.2
Hansen, S.3
-
130
-
-
20344381835
-
the Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment
-
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, and Thal LJ; the Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352: 2379-2388, 2005.
-
(2005)
N Engl J Med
, vol.352
, pp. 2379-2388
-
-
Petersen, R.C.1
Thomas, R.G.2
Grundman, M.3
Bennett, D.4
Doody, R.5
Ferris, S.6
Galasko, D.7
Jin, S.8
Kaye, J.9
Levey, A.10
Pfeiffer, E.11
Sano, M.12
van Dyck, C.H.13
Thal, L.J.14
-
131
-
-
0028643642
-
Superoxide dismutase expression in Parkinson's disease
-
Poirier J, Dea D, Baccichet A, and Thiffault C. Superoxide dismutase expression in Parkinson's disease. Ann NY Acad Sci 738: 116-120, 1994.
-
(1994)
Ann NY Acad Sci
, vol.738
, pp. 116-120
-
-
Poirier, J.1
Dea, D.2
Baccichet, A.3
Thiffault, C.4
-
132
-
-
3042736860
-
Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: Up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease
-
Reddy PH, McWeeney S, Park BS, Manczak M, Gutala RV, Partovi D, Jung Y, Yau V, Searles R, Mori M, and Quinn J. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet 13: 1225-1240, 2004.
-
(2004)
Hum Mol Genet
, vol.13
, pp. 1225-1240
-
-
Reddy, P.H.1
McWeeney, S.2
Park, B.S.3
Manczak, M.4
Gutala, R.V.5
Partovi, D.6
Jung, Y.7
Yau, V.8
Searles, R.9
Mori, M.10
Quinn, J.11
-
133
-
-
33646349444
-
Mitochondrial oxidative damage in aging and Alzheimer's disease: Implications for mitochondrially targeted antioxidant therapeutics
-
Reddy PH. Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics. J Biomed Biotechnol 2006: 31372, 2006.
-
(2006)
J Biomed Biotechnol
, vol.2006
, pp. 31372
-
-
Reddy, P.H.1
-
134
-
-
33745266146
-
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
-
Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, Zvatau-Hind ME, Hosford DA, and Roses AD. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J 6: 246-254, 2006.
-
(2006)
Pharmacogenomics J
, vol.6
, pp. 246-254
-
-
Risner, M.E.1
Saunders, A.M.2
Altman, J.F.3
Ormandy, G.C.4
Craft, S.5
Foley, I.M.6
Zvatau-Hind, M.E.7
Hosford, D.A.8
Roses, A.D.9
-
135
-
-
33847293352
-
Complex disease-associated pharmacogenetics: Drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)
-
Roses AD, Saunders AM, Huang Y, Strum J, Weisgraber KH, and Mahley RW. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Pharmacogenomics J 7: 10-28, 2007.
-
(2007)
Pharmacogenomics J
, vol.7
, pp. 10-28
-
-
Roses, A.D.1
Saunders, A.M.2
Huang, Y.3
Strum, J.4
Weisgraber, K.H.5
Mahley, R.W.6
-
136
-
-
33750706557
-
Transcription meets metabolism in neurodegeneration
-
Ross CA and Thompson LM. Transcription meets metabolism in neurodegeneration. Nat Med 12: 1239-1241, 2006.
-
(2006)
Nat Med
, vol.12
, pp. 1239-1241
-
-
Ross, C.A.1
Thompson, L.M.2
-
137
-
-
0024321178
-
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra
-
Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, and Marsden CD. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 53: 692-697, 1989.
-
(1989)
J Neurochem
, vol.53
, pp. 692-697
-
-
Saggu, H.1
Cooksey, J.2
Dexter, D.3
Wells, F.R.4
Lees, A.5
Jenner, P.6
Marsden, C.D.7
-
138
-
-
0031886330
-
Effects of dichloroacetate in three patients with MELAS
-
Saitoh S, Momoi MY, Yamagata T, Mori Y, and Imai M. Effects of dichloroacetate in three patients with MELAS. Neurology 50: 531-534, 1998.
-
(1998)
Neurology
, vol.50
, pp. 531-534
-
-
Saitoh, S.1
Momoi, M.Y.2
Yamagata, T.3
Mori, Y.4
Imai, M.5
-
139
-
-
0030967165
-
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study
-
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, and Thal LJ. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 336: 1216-1222, 1997.
-
(1997)
N Engl J Med
, vol.336
, pp. 1216-1222
-
-
Sano, M.1
Ernesto, C.2
Thomas, R.G.3
Klauber, M.R.4
Schafer, K.5
Grundman, M.6
Woodbury, P.7
Growdon, J.8
Cotman, C.W.9
Pfeiffer, E.10
Schneider, L.S.11
Thal, L.J.12
-
140
-
-
33744823262
-
The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: A review of treatment options
-
Scaglia F and Northrop JL. The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options. CNS Drugs 20: 443-464, 2006.
-
(2006)
CNS Drugs
, vol.20
, pp. 443-464
-
-
Scaglia, F.1
Northrop, J.L.2
-
141
-
-
33646202306
-
Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial
-
Scaglia F, Northrop JL, Kaufmann P, Englestad K, Wei Y, Jhung S, Sano MC, Shungu DC, Millar WS, Hong X, Gooch CL, Mao X, Pascual JM, Hirano M, Stacpoole PW, DiMauro S, and De Vivo DC. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology 66: 324-330, 2006.
-
(2006)
Neurology
, vol.66
, pp. 324-330
-
-
Scaglia, F.1
Northrop, J.L.2
Kaufmann, P.3
Englestad, K.4
Wei, Y.5
Jhung, S.6
Sano, M.C.7
Shungu, D.C.8
Millar, W.S.9
Hong, X.10
Gooch, C.L.11
Mao, X.12
Pascual, J.M.13
Hirano, M.14
Stacpoole, P.W.15
DiMauro, S.16
De Vivo, D.C.17
-
142
-
-
0037029049
-
Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells
-
Scarpulla RC. Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 286: 81-89, 2002.
-
(2002)
Gene
, vol.286
, pp. 81-89
-
-
Scarpulla, R.C.1
-
143
-
-
33645011201
-
Nuclear control of respiratory gene expression in mammalian cells
-
Scarpulla RC. Nuclear control of respiratory gene expression in mammalian cells. J Cell Biochem 97: 673-683, 2006.
-
(2006)
J Cell Biochem
, vol.97
, pp. 673-683
-
-
Scarpulla, R.C.1
-
144
-
-
0024390719
-
Mitochondrial complex I deficiency in Parkinson's disease
-
Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, and Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1: 1289, 1989.
-
(1989)
Lancet
, vol.1
, pp. 1289
-
-
Schapira, A.H.V.1
Cooper, J.M.2
Dexter, D.3
Jenner, P.4
Clark, J.B.5
Marsden, C.D.6
-
145
-
-
0031909628
-
Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial
-
Schoenen J, Jacquy J, and Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 50: 466-170, 1998.
-
(1998)
Neurology
, vol.50
, pp. 466-170
-
-
Schoenen, J.1
Jacquy, J.2
Lenaerts, M.3
-
147
-
-
8644289377
-
NEALS Consortium. A clinical trial of creatine in ALS
-
Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, Urbinelli L, Qureshi M, Zhang H, Pestronk A, Caress J, Donofrio P, Sorenson E, Bradley W, Lomen-Hoerth C, Pioro E, Rezania K, Ross M, Pascuzzi R, Heiman-Patterson T, Tandan R, Mitsumoto H, Rothstein J, Smith-Palmer T, MacDonald D. and Burke D; NEALS Consortium. A clinical trial of creatine in ALS. Neurology 63: 1656-1661, 2004.
-
(2004)
Neurology
, vol.63
, pp. 1656-1661
-
-
Shefner, J.M.1
Cudkowicz, M.E.2
Schoenfeld, D.3
Conrad, T.4
Taft, J.5
Chilton, M.6
Urbinelli, L.7
Qureshi, M.8
Zhang, H.9
Pestronk, A.10
Caress, J.11
Donofrio, P.12
Sorenson, E.13
Bradley, W.14
Lomen-Hoerth, C.15
Pioro, E.16
Rezania, K.17
Ross, M.18
Pascuzzi, R.19
Heiman-Patterson, T.20
Tandan, R.21
Mitsumoto, H.22
Rothstein, J.23
Smith-Palmer, T.24
MacDonald, D.25
Burke, D.26
more..
-
148
-
-
0036100742
-
Environment, mitochondria, and Parkinson's disease
-
Sherer TB, Betarbet R, and Greenamyre JT. Environment, mitochondria, and Parkinson's disease. Neuroscientist 8: 192-197, 2002.
-
(2002)
Neuroscientist
, vol.8
, pp. 192-197
-
-
Sherer, T.B.1
Betarbet, R.2
Greenamyre, J.T.3
-
149
-
-
0037229425
-
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation
-
Sherer TB, Kim JH, Betarbet R, and Greenamyre JT. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 179: 9-16, 2003.
-
(2003)
Exp Neurol
, vol.179
, pp. 9-16
-
-
Sherer, T.B.1
Kim, J.H.2
Betarbet, R.3
Greenamyre, J.T.4
-
150
-
-
0032500802
-
In vivo effects of pioglitazone on uncoupling protein-2 and -3 mRNA levels in skeletal muscle of hyperglycemic KK mice
-
Shimokawa T, Kato M, Watanabe Y, Hirayama R, Kurosaki E, Shikama H, and Hashimoto S. In vivo effects of pioglitazone on uncoupling protein-2 and -3 mRNA levels in skeletal muscle of hyperglycemic KK mice. Biochem Biophys Res Comm 251: 374-378, 1998.
-
(1998)
Biochem Biophys Res Comm
, vol.251
, pp. 374-378
-
-
Shimokawa, T.1
Kato, M.2
Watanabe, Y.3
Hirayama, R.4
Kurosaki, E.5
Shikama, H.6
Hashimoto, S.7
-
151
-
-
0037222025
-
Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes
-
Shishido S, Koga H, Harada M, Kumemura H, Hanada S, Taniguchi E, Kumashiro R, Ohira H, Sato Y, Namba M, Ueno T, and Sata M. Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes. Hepatology 37: 136-147, 2003.
-
(2003)
Hepatology
, vol.37
, pp. 136-147
-
-
Shishido, S.1
Koga, H.2
Harada, M.3
Kumemura, H.4
Hanada, S.5
Taniguchi, E.6
Kumashiro, R.7
Ohira, H.8
Sato, Y.9
Namba, M.10
Ueno, T.11
Sata, M.12
-
152
-
-
0036771852
-
Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: Evidence of slowing of the functional decline
-
Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, Kurlan R, Molho E, Harrison E, and Lew M; Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 59: 1541-1550, 2002.
-
(2002)
Arch Neurol
, vol.59
, pp. 1541-1550
-
-
Shults, C.W.1
Oakes, D.2
Kieburtz, K.3
Beal, M.F.4
Haas, R.5
Plumb, S.6
Juncos, J.L.7
Nutt, J.8
Shoulson, I.9
Carter, J.10
Kompoliti, K.11
Perlmutter, J.S.12
Reich, S.13
Stern, M.14
Watts, R.L.15
Kurlan, R.16
Molho, E.17
Harrison, E.18
Lew, M.19
-
153
-
-
3042717908
-
Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease
-
Shults CW, Flint Beal M, Song D, and Fontaine D. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Exp Neurol 188: 491-494, 2004.
-
(2004)
Exp Neurol
, vol.188
, pp. 491-494
-
-
Shults, C.W.1
Flint Beal, M.2
Song, D.3
Fontaine, D.4
-
154
-
-
10744231633
-
Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease
-
Simon DK, Lin MT, Zheng L, Liu GJ, Ahn CH, Kim LM, Mauck WM, Twu F, Beal MF, and Johns DR. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease. Neurobiol Aging 25: 71-81, 2004.
-
(2004)
Neurobiol Aging
, vol.25
, pp. 71-81
-
-
Simon, D.K.1
Lin, M.T.2
Zheng, L.3
Liu, G.J.4
Ahn, C.H.5
Kim, L.M.6
Mauck, W.M.7
Twu, F.8
Beal, M.F.9
Johns, D.R.10
-
155
-
-
0021064115
-
Metabolic processes in Alzheimer's disease: Adenine nucleotide content and production of 14CO2 from [U-14C]glucose in vitro in human neocortex
-
Sims NR, Bowen DM, Neary D, and Davison AN. Metabolic processes in Alzheimer's disease: adenine nucleotide content and production of 14CO2 from [U-14C]glucose in vitro in human neocortex. J Neurochem 41: 1329-1334, 1983.
-
(1983)
J Neurochem
, vol.41
, pp. 1329-1334
-
-
Sims, N.R.1
Bowen, D.M.2
Neary, D.3
Davison, A.N.4
-
156
-
-
0023191781
-
Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease
-
Sims NR, Finegan JM, and Blass JP. Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease. Ann Neurol 21: 451-457, 1987.
-
(1987)
Ann Neurol
, vol.21
, pp. 451-457
-
-
Sims, N.R.1
Finegan, J.M.2
Blass, J.P.3
-
157
-
-
0023627915
-
Mitochondrial function in brain tissue in primary degenerative dementia
-
Sims NR, Finegan JM, Blass JP, Bowen DM, and Neary D. Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res 436: 30-38, 1987.
-
(1987)
Brain Res
, vol.436
, pp. 30-38
-
-
Sims, N.R.1
Finegan, J.M.2
Blass, J.P.3
Bowen, D.M.4
Neary, D.5
-
158
-
-
4644351698
-
High frequency of mitochondrial complex I mutations in Parkinson's disease and aging
-
Smigrodzki R, Parks J, and Parker WD. High frequency of mitochondrial complex I mutations in Parkinson's disease and aging. Neurobiol Aging 25: 1273-1281, 2004.
-
(2004)
Neurobiol Aging
, vol.25
, pp. 1273-1281
-
-
Smigrodzki, R.1
Parks, J.2
Parker, W.D.3
-
159
-
-
24944435398
-
Mitochondrial microheteroplasmy and a theory of aging and age-related disease
-
Smigrodzki RM and Khan SM. Mitochondrial microheteroplasmy and a theory of aging and age-related disease. Rejuvenation Res 8: 172-198, 2005.
-
(2005)
Rejuvenation Res
, vol.8
, pp. 172-198
-
-
Smigrodzki, R.M.1
Khan, S.M.2
-
160
-
-
29644434199
-
Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity
-
Smith WW, Jiang H, Pei Z, Tanaka Y, Morita H, Sawa A, Dawson VL, Dawson TM, and Ross CA. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum Mol Genet 14: 3801-3811, 2005.
-
(2005)
Hum Mol Genet
, vol.14
, pp. 3801-3811
-
-
Smith, W.W.1
Jiang, H.2
Pei, Z.3
Tanaka, Y.4
Morita, H.5
Sawa, A.6
Dawson, V.L.7
Dawson, T.M.8
Ross, C.A.9
-
161
-
-
0020685951
-
Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain
-
Sorbi S, Bird ED, and Blass JP. Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 13: 72-78, 1983.
-
(1983)
Ann Neurol
, vol.13
, pp. 72-78
-
-
Sorbi, S.1
Bird, E.D.2
Blass, J.P.3
-
162
-
-
33749999530
-
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
-
St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Hanschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, and Spiegelman BM. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127: 397-408, 2006.
-
(2006)
Cell
, vol.127
, pp. 397-408
-
-
St-Pierre, J.1
Drori, S.2
Uldry, M.3
Silvaggi, J.M.4
Rhee, J.5
Jager, S.6
Hanschin, C.7
Zheng, K.8
Lin, J.9
Yang, W.10
Simon, D.K.11
Bachoo, R.12
Spiegelman, B.M.13
-
163
-
-
1642463791
-
Leigh syndrome caused by mitochondrial DNA G13513A mutation: Frequency and clinical features in Japan
-
Sudo A, Honzawa S, Nonaka I, and Goto Y. Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan. J Hum Genet 49: 92-96, 2004.
-
(2004)
J Hum Genet
, vol.49
, pp. 92-96
-
-
Sudo, A.1
Honzawa, S.2
Nonaka, I.3
Goto, Y.4
-
164
-
-
0029908226
-
Origin and functional consequences of the complex I defect in Parkinson's disease
-
Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, Bennett JP Jr, Davis RE, and Parker WD Jr. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 40: 663-671, 1996.
-
(1996)
Ann Neurol
, vol.40
, pp. 663-671
-
-
Swerdlow, R.H.1
Parks, J.K.2
Miller, S.W.3
Tuttle, J.B.4
Trimmer, P.A.5
Sheehan, J.P.6
Bennett Jr, J.P.7
Davis, R.E.8
Parker Jr., W.D.9
-
165
-
-
0031785692
-
-
Swerdlow RH. Is NADH effective in the treatment of Parkinson's disease? Drugs Aging 13: 263-268, 1998.
-
Swerdlow RH. Is NADH effective in the treatment of Parkinson's disease? Drugs Aging 13: 263-268, 1998.
-
-
-
-
166
-
-
0005427216
-
Role of mitochondria in Parkinson's disease
-
Chesselet MF ed, New Jersey, Humana Press Inc
-
Swerdlow RH. Role of mitochondria in Parkinson's disease. In: Molecular Mechanisms of Neurodegenerative Diseases, Chesselet MF (ed): New Jersey, Humana Press Inc, 2000, pp. 233-270.
-
(2000)
Molecular Mechanisms of Neurodegenerative Diseases
, pp. 233-270
-
-
Swerdlow, R.H.1
-
167
-
-
0034209294
-
Role of mitochondria in amyotrophic lateral sclerosis
-
Swerdlow RH, Parks JK, Pattee G, and Parker WD Jr. Role of mitochondria in amyotrophic lateral sclerosis. Amyotroph Lateral Sclerosis Motor Neuron Disord 1: 185-190, 2000.
-
(2000)
Amyotroph Lateral Sclerosis Motor Neuron Disord
, vol.1
, pp. 185-190
-
-
Swerdlow, R.H.1
Parks, J.K.2
Pattee, G.3
Parker Jr., W.D.4
-
168
-
-
0036982389
-
Mitochondria in Alzheimer's disease
-
Swerdlow RH and Kish SJ. Mitochondria in Alzheimer's disease. Int Rev Neurobiol 53: 341-385, 2002.
-
(2002)
Int Rev Neurobiol
, vol.53
, pp. 341-385
-
-
Swerdlow, R.H.1
Kish, S.J.2
-
169
-
-
33748137342
-
Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease
-
Swerdlow RH, Weaver B, Grawey A, Wenger C, Freed E, and Worrall BB. Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease. J Neurol Sci 247: 224-230, 2006.
-
(2006)
J Neurol Sci
, vol.247
, pp. 224-230
-
-
Swerdlow, R.H.1
Weaver, B.2
Grawey, A.3
Wenger, C.4
Freed, E.5
Worrall, B.B.6
-
170
-
-
34347353834
-
Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies
-
Epub ahead of print
-
Swerdlow RH. Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies. J Neurosci Res [Epub ahead of print], 2007.
-
(2007)
J Neurosci Res
-
-
Swerdlow, R.H.1
-
171
-
-
0035002174
-
Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders
-
Tarnopolsky MA and Beal MF. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann Neurol 49: 561-574, 2001.
-
(2001)
Ann Neurol
, vol.49
, pp. 561-574
-
-
Tarnopolsky, M.A.1
Beal, M.F.2
-
172
-
-
12444296116
-
Gaucher disease with parkinsonian manifestations: Does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?
-
Tayebi N, Walker J, Stubblefield B, Orvisky E, LaMarca ME, Wong K, Rosenbaum H, Schiffman R, Bembi B, and Sidransky E. Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79: 104-109, 2003.
-
(2003)
Mol Genet Metab
, vol.79
, pp. 104-109
-
-
Tayebi, N.1
Walker, J.2
Stubblefield, B.3
Orvisky, E.4
LaMarca, M.E.5
Wong, K.6
Rosenbaum, H.7
Schiffman, R.8
Bembi, B.9
Sidransky, E.10
-
173
-
-
0031038812
-
Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids
-
Taylor RW, Chinnery PF, Turnbull DM, and Lightowlers RN. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet 15: 212-215, 1997.
-
(1997)
Nat Genet
, vol.15
, pp. 212-215
-
-
Taylor, R.W.1
Chinnery, P.F.2
Turnbull, D.M.3
Lightowlers, R.N.4
-
174
-
-
0344738681
-
Idebenone treatment fails to slow cognitive decline in Alzheimer's disease
-
Thal LJ, Grundman M, Berg J, Ernstrom K, Margolin R, Pfeiffer E, Weiner MF, Zamrini E, and Thomas RG. Idebenone treatment fails to slow cognitive decline in Alzheimer's disease. Neurology 61: 1498-1502, 2003.
-
(2003)
Neurology
, vol.61
, pp. 1498-1502
-
-
Thal, L.J.1
Grundman, M.2
Berg, J.3
Ernstrom, K.4
Margolin, R.5
Pfeiffer, E.6
Weiner, M.F.7
Zamrini, E.8
Thomas, R.G.9
-
175
-
-
2642580016
-
Premature ageing in mice expressing defective mitochondrial DNA polymerase
-
Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly Y, Gidlof S, Oldfors A, Wibom R, Tornell J, Jacobs HT, and Larsson NG. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417-423, 2004.
-
(2004)
Nature
, vol.429
, pp. 417-423
-
-
Trifunovic, A.1
Wredenberg, A.2
Falkenberg, M.3
Spelbrink, J.N.4
Rovio, A.T.5
Bruder, C.E.6
Bohlooly, Y.7
Gidlof, S.8
Oldfors, A.9
Wibom, R.10
Tornell, J.11
Jacobs, H.T.12
Larsson, N.G.13
-
176
-
-
1642578313
-
Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture
-
Trimmer PA, Keeney PM, Borland MK, Simon FA, Almeida J, Swerdlow RH, Parks JP, Parker WD Jr, and Bennett JP Jr. Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture. Neurobiol Dis 15: 29-39, 2004.
-
(2004)
Neurobiol Dis
, vol.15
, pp. 29-39
-
-
Trimmer, P.A.1
Keeney, P.M.2
Borland, M.K.3
Simon, F.A.4
Almeida, J.5
Swerdlow, R.H.6
Parks, J.P.7
Parker Jr, W.D.8
Bennett Jr., J.P.9
-
177
-
-
3242707016
-
Analysis of European mitochondrial haplogroups with Alzheimer disease risk
-
van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW, Schmechel DE, Murali Doraiswamy P, Gilbert JR, Haines JL, Vance JM, and Pericak-Vance MA. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365: 28-32, 2004.
-
(2004)
Neurosci Lett
, vol.365
, pp. 28-32
-
-
van der Walt, J.M.1
Dementieva, Y.A.2
Martin, E.R.3
Scott, W.K.4
Nicodemus, K.K.5
Kroner, C.C.6
Welsh-Bohmer, K.A.7
Saunders, A.M.8
Roses, A.D.9
Small, G.W.10
Schmechel, D.E.11
Murali Doraiswamy, P.12
Gilbert, J.R.13
Haines, J.L.14
Vance, J.M.15
Pericak-Vance, M.A.16
-
178
-
-
0141959170
-
Creatine supplementation in Huntington's disease: A placebo-controlled pilot trial
-
Verbessem P, Lemiere J, Eijnde BO, Swinnen S, Vanhees L, Van Leemputte M, Hespel P, and Dom R. Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial. Neurology 61: 925-930, 2003.
-
(2003)
Neurology
, vol.61
, pp. 925-930
-
-
Verbessem, P.1
Lemiere, J.2
Eijnde, B.O.3
Swinnen, S.4
Vanhees, L.5
Van Leemputte, M.6
Hespel, P.7
Dom, R.8
-
179
-
-
0026587335
-
Mitochondrial genetics: A paradigm for aging and degenerative diseases?
-
Wallace, DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256: 628-632, 1992.
-
(1992)
Science
, vol.256
, pp. 628-632
-
-
Wallace, D.C.1
-
180
-
-
33644592598
-
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: A preliminary study
-
Watson GS, Cholerton BA, Reger MA, Baker LD, Phymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, Kahn SE, Keeling ML, and Craft S. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 13: 950-958, 2005.
-
(2005)
Am J Geriatr Psychiatry
, vol.13
, pp. 950-958
-
-
Watson, G.S.1
Cholerton, B.A.2
Reger, M.A.3
Baker, L.D.4
Phymate, S.R.5
Asthana, S.6
Fishel, M.A.7
Kulstad, J.J.8
Green, P.S.9
Cook, D.G.10
Kahn, S.E.11
Keeling, M.L.12
Craft, S.13
-
181
-
-
0031864678
-
Current opinions in headache pathogenesis: Introduction and synthesis
-
Welch KMA. Current opinions in headache pathogenesis: introduction and synthesis. Curr Opin Neurol 11: 193-197, 1998.
-
(1998)
Curr Opin Neurol
, vol.11
, pp. 193-197
-
-
Welch, K.M.A.1
-
182
-
-
33750437278
-
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration
-
Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, Lazarowski ER, Gilbert ML, Moron GJ, Bammler TK, Strand AD, Cui L, Bever RP, Easley CN, Smith AC, Krainc D, Luquet S, Sweet IR, Schwartz MW, and La Spada AR Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab 4: 349-362, 2006.
-
(2006)
Cell Metab
, vol.4
, pp. 349-362
-
-
Weydt, P.1
Pineda, V.V.2
Torrence, A.E.3
Libby, R.T.4
Satterfield, T.F.5
Lazarowski, E.R.6
Gilbert, M.L.7
Moron, G.J.8
Bammler, T.K.9
Strand, A.D.10
Cui, L.11
Bever, R.P.12
Easley, C.N.13
Smith, A.C.14
Krainc, D.15
Luquet, S.16
Sweet, I.R.17
Schwartz, M.W.18
La Spada, A.R.19
-
183
-
-
0037066459
-
Regulation of mitochondrial biogenesis in skeletal muscle by CaMK
-
Wu H, Kanatous SB, Thurmond FA, Gallardo T, Isotani E, Bassel-Duby R, and Williams RS. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296: 349-352, 2002.
-
(2002)
Science
, vol.296
, pp. 349-352
-
-
Wu, H.1
Kanatous, S.B.2
Thurmond, F.A.3
Gallardo, T.4
Isotani, E.5
Bassel-Duby, R.6
Williams, R.S.7
-
184
-
-
19244365650
-
Thiazolidinediones
-
Yki-Jarvinen H. Thiazolidinediones. New Engl J Med 351: 1106-1118, 2004.
-
(2004)
New Engl J Med
, vol.351
, pp. 1106-1118
-
-
Yki-Jarvinen, H.1
-
185
-
-
33846502074
-
Coenzyme Q10: A review of its promise as a neuroprotectant
-
Young AJ, Johnson S, Steffens DC, and Doraiswamy PM. Coenzyme Q10: A review of its promise as a neuroprotectant. CNS Spectr 12: 62-68, 2007.
-
(2007)
CNS Spectr
, vol.12
, pp. 62-68
-
-
Young, A.J.1
Johnson, S.2
Steffens, D.C.3
Doraiswamy, P.M.4
-
186
-
-
0037159179
-
Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk
-
Zhang SM, Hernan MA, Chen H, Spiegelman D, Willett WC, and Ascherio A. Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology 59: 1161-1169, 2002.
-
(2002)
Neurology
, vol.59
, pp. 1161-1169
-
-
Zhang, S.M.1
Hernan, M.A.2
Chen, H.3
Spiegelman, D.4
Willett, W.C.5
Ascherio, A.6
-
187
-
-
18044379574
-
Mitochondrial DNA mutations activate programmed cell survival in the mouse heart
-
Zhang D, Mott JL, Chang SW, Stevens M, Mikolajczak P, and Zassenhaus HP. Mitochondrial DNA mutations activate programmed cell survival in the mouse heart. Am J Physiol Heart Circ Physiol 288: H2476-H2483, 2005.
-
(2005)
Am J Physiol Heart Circ Physiol
, vol.288
-
-
Zhang, D.1
Mott, J.L.2
Chang, S.W.3
Stevens, M.4
Mikolajczak, P.5
Zassenhaus, H.P.6
|